Zimmer Biomet Holdings, Inc. (ZBH)
Unveiling Zimmer (ZBH) Q4 Outlook: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Zimmer (ZBH) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Zimmer Biomet to Report Q4 Earnings: Here's What to Expect
ZBH is set to report Q4 on Feb. 10, with revenues seen at $2.20B and EPS at $2.38 as hips, knees, robotics and S.E.T. drive growth estimates.
Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
How the OneStep Partnership Could Drive Growth for ZBH Stock
Zimmer Biomet teams up with OneStep to integrate mobility analytics into mymobility, empowering surgeons and patients while advancing its connected care strategy.
Why Is Zimmer (ZBH) Up 5.3% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript
Zimmer Biomet Holdings, Inc. ( ZBH ) Jefferies London Healthcare Conference 2025 November 18, 2025 7:00 AM EST Company Participants Ivan Tornos - President, CEO & Chairman of the Board Suketu Upadhyay - CFO and Executive VP of Finance, Operations & Supply Chain Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division All right. Great. Thanks for joining us for our next session here at the Jefferies Healthcare Conference.
Could Zimmer Biomet Stock Be Your Next Buy?
Zimmer Biomet (ZBH) could be a strong choice for your investment portfolio, due to its high cash yield, solid fundamentals, and discounted valuation. Companies like this have the capacity to leverage cash for additional revenue growth or to reward their shareholders through dividends or buybacks.
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop
Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2025 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. ( ZBH ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants David DeMartino - Senior Vice President of Investor Relations Ivan Tornos - President, CEO & Chairman of the Board Suketu Upadhyay - CFO and Executive VP of Finance, Operations & Supply Chain Conference Call Participants Robert Marcus - JPMorgan Chase & Co, Research Division Travis Steed - BofA Securities, Research Division David Roman - Goldman Sachs Group, Inc., Research Division Caitlin Cronin - Canaccord Genuity Corp., Research Division Patrick Wood - Morgan Stanley, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Matthew Taylor - Jefferies LLC, Research Division Joanne Wuensch - Citigroup Inc., Research Division Matthew O'Brien - Piper Sandler & Co., Research Division Edward Ridley-Day - Rothschild & Co Redburn, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Danielle Antalffy - UBS Investment Bank, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, November 5, 2025.
